Association between treatment response and dose of blonanserin transdermal patch in patients with acute schizophrenia: A post hoc cluster analysis based on baseline psychiatric symptoms
Abstract Aim To explore the optimal dose of blonanserin transdermal patch (BNS‐P) based on baseline psychiatric symptomatic characteristics during acute schizophrenia. Methods A post hoc cluster analysis was conducted using data from a 6‐week randomized, double‐blind, placebo‐controlled study of BNS...
Saved in:
| Main Authors: | Yoshiteru Takekita, Yuji Matsumoto, Takahiro Masuda, Kazumasa Yoshida, Yosuke Koshikawa, Masaki Kato |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2024-12-01
|
| Series: | Neuropsychopharmacology Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/npr2.12490 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Transdermal patches: Design and current approaches to painless drug delivery
by: Al Hanbali Othman A., et al.
Published: (2019-06-01) -
High-Fat Meal Increase Blonanserin Bioavailability 5-Fold in Chinese Healthy Subjects
by: Sun X, et al.
Published: (2025-07-01) -
Blonanserin treatment in patients with methamphetamine-induced psychosis comorbid with intellectual disabilities
by: Okazaki K, et al.
Published: (2016-12-01) -
A randomized trial of aripiprazole vs blonanserin for the treatment of acute schizophrenia and related disorders
by: Kishi T, et al.
Published: (2016-11-01) -
Evaluating the pharmacokinetics and safety of blonanserin tablets and Lonasen®: a randomized, open-label, two-period, two-sequence, self-crossover phase I clinical trial
by: Bo Qiu, et al.
Published: (2025-01-01)